Vantage Consulting Group Inc Royalty Pharma PLC Transaction History

Vantage Consulting Group Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$26.26 - $31.38 $15.6 Million - $18.6 Million	-593,190 Reduced 91.16%	57,500 $1.56 Million
Q2 2023 Aug 11, 2023	SELL	$29.6 - $36.56 $11 Million - $13.6 Million	-371,504 Reduced 36.34%	650,690 $20 Million
Q3 2022 Nov 14, 2022	SELL	$39.88 - $44.65 $1.18 Million - $1.33 Million	-29,701 Reduced 2.82%	1,022,194 $41.1 Million
Q2 2022 Aug 09, 2022	SELL	$37.53 - $44.22 $62.9 Million - $74.1 Million	-1,675,959 Reduced 61.44%	1,051,895 $44.2 Million
Q1 2022 May 16, 2022	SELL	$37.46 - $42.44 $70.2 Million - $79.5 Million	-1,873,298 Reduced 40.71%	2,727,854 $106 Million
Q4 2021 Feb 14, 2022	SELL	$35.17 - $42.48 $115 Million - $139 Million	-3,261,390 Reduced 41.48%	4,601,152 $183 Million
Q3 2021 Nov 10, 2021	SELL	$36.14 - $42.24 $52 Million - $60.8 Million	-1,439,903 Reduced 15.48%	7,862,542 $284 Million
Q2 2021 Aug 11, 2021	BUY	$39.85 - $46.63 $23.8 Million - $27.8 Million	596,894 Added 6.86%	9,302,445 $381 Million
Q1 2021 May 14, 2021	SELL	$42.34 - $52.82 $541 Million - $675 Million	-12,771,731 Reduced 59.47%	8,705,551 $380 Million
Q4 2020 Feb 12, 2021	BUY	$36.12 - $50.05 $776 Million - $1.07 Billion	21,477,282 New	21,477,282 $1.07 Billion

413

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Vantage Consulting Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vantage Consulting Group Inc with notifications on news.